GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

GoodRx Holdings GDRX · USD

Health Care · US listing · 🇺🇸 United States

Compare

3.65

+3.99%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About GoodRx Holdings

From its filings with the US Securities and Exchange Commission

SEC filings

GoodRx Holdings is based in Santa Monica, California and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker GDRX. The SEC classifies its business as computer processing & data preparation. In the fiscal year to 31 December 2025, it reported revenue of $796.9m and net income of $30.4m. At that date it held total assets of $1.40bn and shareholders' equity of $616.3m. By business, Prescription transactions revenue brought in 68.3% of revenue, followed by Pharma manufacturer solutions revenue at 19.0% and Subscription revenue at 10.5%.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Technology
Listed since
23 Sept 2020
Employees
738
Head office
2701 OLYMPIC BOULEVARD, SANTA MONICA, CA, 90404
Incorporated in
DE
Classification
Services-Computer Processing & Data Preparation
Filer status
Accelerated filer

Leadership

Pay as last reported

  • Mr. Trevor BezdekCo-Chairman of the Board, Co-Founder, since 2011$853,918
  • Mr. Scott WagnerCo-Chairman of the Board, since 2023$9.8m
  • Ms. Wendy BarnesPresident, Chief Executive Officer, Director, since 2025
  • Mr. Douglas HirschCo-Founder, Director, since 2011$515,654
  • Mr. Christopher McginnisChief Financial Officer, Treasurer
  • Mr. Romin NabieyChief Accounting Officer$942,603
  • Ms. Laura JensenChief Commercial Officer, President - Pharma Solutions
  • Mr. Christopher AdamsIndependent Director
  • Mr. Ronald BruehlmanIndependent Director$425,756
  • Mr. Ian ClarkIndependent Director$647,435
  • Mr. Dipanjan DebIndependent Director
  • Ms. Kelly KennedyIndependent Director$299,780

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • GoodRx provides free access to prescription drug pricing across the US with negotiated codes.
  • The platform offers telehealth consultations and comprehensive healthcare research for consumers.
  • GoodRx has 952 full-time employees supporting its digital healthcare services in the US.

Weaknesses

  • The company's business model relies on free consumer services without direct revenue from users.
  • GoodRx operates primarily in the US market with limited international expansion.
  • The firm's telehealth services may face competition from established healthcare providers.

Opportunities

  • Expanding subscription services with features like refill reminders and price alerts in the US market.
  • Increasing partnerships with pharma manufacturers for additional revenue streams.
  • Growing demand for digital healthcare platforms in the US healthcare sector.

Threats

  • Regulatory changes in the US healthcare sector could impact pricing transparency.
  • Competition from other digital health platforms offering similar services.
  • Economic downturns may reduce consumer spending on healthcare services.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.